Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of CNSP will decline by -0.09% over the next 2 Weeks and hit $7.83 by Monday, May 18, 2026. In that time frame, CNSP's share price is expected to range between $7.56 and $8.12.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| May 18, 2026 | 7.56 | 7.83 | 8.12 |
| May 15, 2026 | 7.46 | 7.73 | 8.01 |
| May 14, 2026 | 7.51 | 7.79 | 8.09 |
| May 13, 2026 | 7.53 | 7.81 | 8.08 |
| May 12, 2026 | 7.62 | 7.91 | 8.20 |
| May 11, 2026 | 7.55 | 7.84 | 8.11 |
| May 8, 2026 | 7.47 | 7.74 | 8.01 |
| May 7, 2026 | 7.50 | 7.79 | 8.07 |
| May 6, 2026 | 7.52 | 7.81 | 8.11 |
| May 5, 2026 | 7.62 | 7.91 | 8.18 |
CNSP shares rose +239.39% in Monday, May 4, 2026's trading session, rising from a previous close of $2.31 to move at $7.84. The stock demonstrated notable intraday movement (see CNSP's key stats for a full breakdown), fluctuating between $7.32 and $10.54, a +43.99% trading range. While recent weeks have seen some volatility, CNSP has managed to secure a +208.66% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 83.17M shares changing hands, 83.17M more than the previous session. This amounted to $652.09M in total market activity.
Will CNSP Continue Its Upward Trend?
According to analyst ratings and projections for CNSP, CNS Pharmaceuticals, Inc. shares are anticipated to increase by +3.43%, potentially reaching $8.12 per share by May 18, 2026. Short-term technical indicators currently suggest a neutral sentiment for CNSP. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the CNSP stock forecast, now is a good time to buy CNSP stock because its current trading price is +0.09% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on CNSP covering social and institutional perspectives.
CNSP Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into CNSP's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 84.64% to 94.64%) indicate the stock is in a strong bullish momentum phase. The 50-day RSI, at 58.23%, suggests a neutral medium-term outlook. However, the 100-day RSI, at 41.37%, maintains a neutral outlook for the long term. Insights into CNSP's shareholder base show how institutional investors are positioning themselves during these momentum shifts
CNS Pharmaceuticals Short-Term Forecasts
CNSP Forecast For Next 5 Days
Our algorithm anticipates CNS Pharmaceuticals (CNSP) stock could hit $6.93 by May 12, 2026. This represents a -11.59% rise from today's price, following a +20.97% change over the past five days.
CNSP Forecast For Next 30 Days
Based on analysis of market trends, the outlook for CNS Pharmaceuticals, Inc. (CNSP) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $6.81, which would mean a -13.14% decrease from the current price of $7.84. Projections for this period range from a high of $7.64 to a low of $6.05.
CNSP Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for CNS Pharmaceuticals's price over the next three months point to a drop. CNSP stock is expected to peak at $1,271.08 on Jun 22, 2026 before potentially dipping to $0.00 on Aug 05, 2026. On average, CNSP is likely to trade around $0.01 in the coming 90 days.
CNS Pharmaceuticals Stock Forecast 2025
Based on our predictive models, CNS Pharmaceuticals (CNSP) is expected to trade between $0.00 and $1,347.73 throughout 2026. This would result in an average price of $0.00, potentially offering investors a -100.00% return from current levels.
CNS Pharmaceuticals, Inc. Monthly Forecast 2026–2027
May 2026
According to our latest forecast models, CNS Pharmaceuticals, Inc. (CNSP) is positioned to show a strong performance in May 2026. The price is predicted to move between $0.00 and $1202.60, settling at an average of $0.01. This could translate to a -99.87% loss.
June 2026
Based on current market signals, CNS Pharmaceuticals, Inc. is projected to trend june 2026. We forecast a trading range from $0.00 to $1271.08, with a likely average price of $0.01. Investors could expect a potential return of -99.87%.
July 2026
Our predictive algorithms indicate CNS Pharmaceuticals, Inc. stock may see a shift in July 2026. The expected range spans $0.00–$1150.77, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
August 2026
Analyzing established trends, CNS Pharmaceuticals, Inc. looks set to move in August 2026. Projections place the stock between $0.00 and $1269.53, averaging around $0.00. This suggests a -100.00% loss from current levels.
September 2026
Market indicators suggest CNS Pharmaceuticals, Inc. could experience notable changes during September 2026. Prices could fluctuate within $0.00 to $1233.65, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
October 2026
Forecasting for October 2026, models estimate that CNS Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1347.73, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
November 2026
According to our latest forecast models, CNS Pharmaceuticals, Inc. (CNSP) is positioned to show a strong performance in November 2026. The price is predicted to move between $0.00 and $1157.06, settling at an average of $0.00. This could translate to a -100.00% loss.
December 2026
Based on current market signals, CNS Pharmaceuticals, Inc. is projected to trend december 2026. We forecast a trading range from $0.00 to $1193.50, with a likely average price of $0.00. Investors could expect a potential return of -100.00%.
January 2027
Our predictive algorithms indicate CNS Pharmaceuticals, Inc. stock may see a shift in January 2027. The expected range spans $0.00–$1150.28, with an average target of $0.00. This represents a cautious outlook and a possible loss of -100.00%.
February 2027
Analyzing established trends, CNS Pharmaceuticals, Inc. looks set to move in February 2027. Projections place the stock between $0.00 and $1197.03, averaging around $0.00. This suggests a -100.00% loss from current levels.
March 2027
Market indicators suggest CNS Pharmaceuticals, Inc. could experience notable changes during March 2027. Prices could fluctuate within $0.00 to $1140.24, with a midpoint forecast of $0.00. The stock might deliver a -100.00% loss.
April 2027
Forecasting for April 2027, models estimate that CNS Pharmaceuticals, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1260.87, averaging $0.00. This signals a cautious trajectory with potential returns around -100.00%.
May 2027
According to our latest forecast models, CNS Pharmaceuticals, Inc. (CNSP) is positioned to show a strong performance in May 2027. The price is predicted to move between $0.00 and $1046.93, settling at an average of $0.00. This could translate to a -100.00% loss.
CNSP's history of dividends and stock splits also plays a role in long-term investor confidence.